New patent expiration for Alnylam Pharms drug GIVLAARI
Annual Drug Patent Expirations for GIVLAARI Givlaari is a drug marketed by Alnylam Pharms Inc and is included in one […]
New patent expiration for Alnylam Pharms drug GIVLAARI Read Post »
Annual Drug Patent Expirations for GIVLAARI Givlaari is a drug marketed by Alnylam Pharms Inc and is included in one […]
New patent expiration for Alnylam Pharms drug GIVLAARI Read Post »
Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It
TASIGNA (nilotinib hydrochloride) Novartis Patent: 7,169,791 Expiration: Jan 4, 2024 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of December 31, 2023 Read Post »
Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It
Annual Drug Patent Expirations for VICTOZA Victoza is a drug marketed by Novo Nordisk Inc and is included in one
New patent expiration for Novo Nordisk drug VICTOZA Read Post »
Annual Drug Patent Expirations for CHLORAPREP+ONE-STEP Chloraprep One-step is a drug marketed by Becton Dickinson Co and is included in
New patent expiration for Becton Dickinson drug CHLORAPREP ONE-STEP Read Post »
Annual Drug Patent Expirations for CHLORAPREP+WITH+TINT Chloraprep With Tint is a drug marketed by Becton Dickinson Co and is included
New patent expiration for Becton Dickinson drug CHLORAPREP WITH TINT Read Post »
Annual Drug Patent Expirations for NOCDURNA Nocdurna is a drug marketed by Ferring Pharms Inc and is included in one
New patent expiration for Ferring Pharms drug NOCDURNA Read Post »
Annual Drug Patent Expirations for COREG+CR Coreg Cr is a drug marketed by Woodward and is included in one NDA.
New patent expiration for Woodward drug COREG CR Read Post »
Get fresh news and insights, drug patent expirations & more…